hvanspall Profile Banner
Harriette Van Spall, MD MPH 🇨🇦 Profile
Harriette Van Spall, MD MPH 🇨🇦

@hvanspall

Followers
18K
Following
70K
Media
2K
Statuses
44K

Cardiologist @McMasterU, Sr Scientist @PHRIresearch, #Implementation Dir @BaimInstitute, Editor @CircAHA, ChairElect #HF Council @American_Heart, Alum @Harvard

@hvanspall.bsky.social
Joined September 2017
Don't wanna be here? Send us removal request.
@hvanspall
Harriette Van Spall, MD MPH 🇨🇦
3 years
Thank you @CIHR_IRSC @SCC_CCS for this award which I don’t deserve so early in mid-career, but which I’m grateful for. Indebted to my family, team, collaborators, funders, & to 🇨🇦 for giving this immigrant a chance. So grateful to my nominators. Miss you, dad.. this one’s for you
@CIHR_ICRH
CIHR-ICRH | L'ISCR des IRSC
3 years
📢 Congratulations to Dr. Harriette Van Spall, recipient of the 2022 CIHR-ICRH/CCS Mid-Career Lecturer Award in Cardiovascular Sciences! Learn more: https://t.co/LmcKgqZq6P @SCC_CCS
18
20
246
@Gurleen_Kaur96
Gurleen Kaur, MD
1 day
Excited to be joining @theheartorg for their 6th Annual Going Back to the Heart of Cardiology meeting as a @CardioNerds Conference Scholar with @sukritibanthiya 🔗 https://t.co/0Hga9aywBJ
0
8
31
@drbennisahmed
Ahmed Bennis MD 🫀
8 hours
The Basics of Metabolic Dysfunction–Associated Steatotic Liver Disease for Cardiologists: Pathophysiology, Diagnosis, and Treatment MASLD and cardiovascular disease share overlapping pathophysiological mechanisms including insulin resistance, chronic inflammation, oxidative
0
7
17
@SripalBangalore
Sripal Bangalore
20 hours
2024 ESC guidelines downgraded DCB in preference to DES for re-DES ISR based on increased risk of TLR with DCB. Is that still valid? Check out our latest publication. @realarainmd @evandrofilhobr @mirvatalasnag @hvanspall @SVRaoMD @Hragy @ziadalinyc @mmamas1973 @Ajar_Kochar
@haisummaqsood
Haisum Maqsood
21 hours
1/ Check out our latest publication in @circintv #circ interventions evaluating DCB, DES, or POBA for in-stent coronary restenosis. https://t.co/YLkD1I4HJV @SripalBangalore @n_kleiman @robertshiuzhang
5
13
37
@David_Ouyang
David Ouyang, MD
2 days
On the heels of #AHA25, EchoPrime is published in @Nature! EchoPrime has the strong performance in a wide range of echo interpretation tasks and is validated across 5 international hospitals. Led by @milos_ai and @bryandhe. 1/n
@David_Ouyang
David Ouyang, MD
1 year
1/n We are excited to announce EchoPrime – the first echocardiography AI model capable of evaluating a full transthoracic echocardiogram study, identify the most relevant videos, and produce a comprehensive interpretation! Great work lead by @milos_ai, EchoPrime is the largest
14
42
173
@JACCJournals
JACC Journals
2 days
Visceral fat is the hidden driver linking CKD and HFpEF. This Special Communication reframes adiposity as a pathogenic organ fueling renal and cardiac decline. #HFpEF #CKD More in the newest issue of #JACC: https://t.co/fuskMBO4Hb #CardioX
0
15
48
@hvanspall
Harriette Van Spall, MD MPH 🇨🇦
1 year
Trip to #Ypers #Flanders, planned by 2 kids who wanted to understand WWI Strength of #allies Horror in #trenches #Sacrifice of boys who gave all >650K Canadians deployed, 66K lost ~20 mill lives gone, more maimed The price of #fascism, paid for in blood #WeRemember
2
7
30
@AJBloodMD
AJ Blood, MD, MS
4 days
Thank you for highlighting our work! A team effort
@hvanspall
Harriette Van Spall, MD MPH 🇨🇦
4 days
#Discussion on @AJBloodMD’s fabulous presentation of #CoPilot #DigitalHealth #Pragmatic #RCT of 300 people + single arm study of 203 people with #HF in #MGHBrigham system. 34% vs 0% in PEP of prescription of right number of #GDMT pillars for EF at 3 mo #AHA2025 #AHA25
0
1
8
@CircAHA
Circulation
3 days
#AHA25 The high-dose influenza vaccine appears to provide broader protection against severe cardio-respiratory events than standard-dose vaccine in older adults including those with established cardiovascular disease https://t.co/kYjd5tOcAt @niklasdj1 @KiraJanstrup @TorBiering
Tweet card summary image
ahajournals.org
Background: The high-dose inactivated influenza vaccine (HD-IIV) has demonstrated superior protection against a range of hospitalization endpoints versus standard-dose inactivated influenza vaccine...
0
5
16
@VeteransENG_CA
Veterans Affairs CA
2 days
November 11, the most unforgettable day of the year. Today, we pause to honour those who have served and continue to serve for peace and freedom – at home and around the world.   #CanadaRemembers
123
1K
4K
@hvanspall
Harriette Van Spall, MD MPH 🇨🇦
2 days
In this small RCT of #coffee vs no ☕️ post AF cardioversion - w/ some between-group diffs in baseline characteristics, modest ☕️ intake in ☕️ group, & clinical follow-up/investigations at the discretion of regular physicians - ☕️ intake appeared to ⬇️ #AF recurrence. #AHA25
@kamleshkhunti
Prof Kamlesh Khunti
2 days
☕❤️ Coffee lovers, rejoice! A new RCT puts the controversy to bed? Caffeinated coffee may reduce rather than trigger atrial fibrillation (AF) recurrence. Among 200 adults post-cardioversion for AF or atrial flutter: ➡️ 1 cup/day of caffeinated coffee ↓ AF recurrence by 39%
0
5
21
@modeldoc
Modele Ogunniyi, MD, MPH
6 days
Humbled to receive this award, reflecting the excellence & commitment to #healthequity of our @GradyHealth HF team, esp our #HF APPs. Grateful to our patients whose trust inspires me everyday & our @EmoryatGrady research team for advancing equity-focused #cardiovascular science🙏🏾
@hfcollaboratory
HF Collaboratory
6 days
We’re proud to spotlight Allen Jeremias, Farrell Mendelsohn and Modele Ogunniyi as winners of this year’s Top Principal Investigators recognized by the Heart Failure Collaboratory. Congratulations on your leadership and dedication to advancing site-based trials👏🏻
1
3
21
@AnastasiaSMihai
Dr Anastasia Mihailidou FAHA FCSANZ FESC
3 days
One leg (1.5 hour flight to Dallas) completed🙏 & now waiting for flight home 17.5 hours & hope we leave on time What an amazing time #AHA25 & friendships 🙏♥️ Safe travels home everyone👋
3
3
40
@hvanspall
Harriette Van Spall, MD MPH 🇨🇦
3 days
In the #Tuxedo2 #RCT of 1800 patients with #T2DM & #MVD in India undergoing #PCI, #ticagrelor not proven non-inferior to #prasugrel on PEP of #MACE Point estimates favoured prasugrel across endpoints Non-inferiority margin 5% Congrats @SripalBangalore & team #AHA25 @mmamas1973
@radcliffeCARDIO
Radcliffe Cardiology
3 days
🎙️NEW #AHA25 Late Breaker Discussion ✨ Dr @SripalBangalore joins host 🌟Dr @hvanspall to discuss findings from the TUXEDO-2 trial 📽️Watch here👉 https://t.co/Nchc2kdf6m 📊#Ticagrelor did not meet non-inferiority compared to #prasugrel when added to aspirin as part of dual
1
8
32
@iamritu
Ritu Thamman MD
4 days
The brilliant rendition of somewhere over the rainbow 🌈 by the incredible @NorthwellHealth nurse’s choir!!! So uplifting & full of grace!!! #AHA2025
1
12
41
@drstaceyrosen
Stacey Rosen, M.D.
3 days
Thank you @hvanspall ! Honored to be your friend and colleague in the work to improve the health of women !❤️❤️@American_Heart
@hvanspall
Harriette Van Spall, MD MPH 🇨🇦
3 days
@drstaceyrosen a true inspiration in achievement, kindness, & humility! Congratulations Dr Rosen on your presidency. #AHA25
0
1
12
@ShahzebKhanMD
Shahzeb Khan
3 days
Basics of MASLD for Cardiologists- Pathophysiology, Diagnosis and Treatment Now published in @JACCJournals https://t.co/khg4Fk1cvc
3
83
289
@hvanspall
Harriette Van Spall, MD MPH 🇨🇦
3 days
#BetterBP RCT: incentivizing patients w possible daily #lottery win for 💊 #adherence - as measured digitally by 💊 bottle opening - did not ⬇️ #BP at 6 mo 💊 bottle openings ⬆️ w lottery, but were not sustained over time Were 💊s consumed? #AHA25 -#SafetyNet @HeartOTXHeartMD
@radcliffeCARDIO
Radcliffe Cardiology
4 days
🎙️NEW #AHA25 Late Breaker Discussion 🌟 Host Dr @hvanspall is joined by Dr John Dodson, principal investigator of the BETTER-BP trial. 📽️Watch here👉 https://t.co/hLc876HQgY 📊BETTER-BP found behavioral economics-based lottery successfully doubled the rate of adequate
1
7
25
@radcliffeCARDIO
Radcliffe Cardiology
3 days
🎙️NEW #AHA25 Late Breaker Discussion ✨ Dr @SripalBangalore joins host 🌟Dr @hvanspall to discuss findings from the TUXEDO-2 trial 📽️Watch here👉 https://t.co/Nchc2kdf6m 📊#Ticagrelor did not meet non-inferiority compared to #prasugrel when added to aspirin as part of dual
0
3
9